PC3002 - Cardiovascular and Renal Therapeutics for Pharmacists

Credit points:	03
Year:	2017
Student Contribution Band:	Band 2
Administered by:	College of Medicine & Dentistry

Available to students enrolled in level 3 of the Bachelor of Pharmacy.

Cardiovascular disease is the major cause of morbidity and mortality in the Australian population and renal disease is of high prevalence in tropical areas and indigenous populations. This subject will address the incidence, causative factors, pathophysiology, therapeutics and prevention of cardiovascular and renal problems relevant to pharmacy practice. An emphasis will be placed on an understanding of the Quality Use of Medicines (QUM) with particular relevance to issues experienced by older Australians, indigenous and rural populations. The student will also be exposed to transplant medicine and how pharmacists can assist with determining appropriate drug regimens used in these patients.

Learning Outcomes

• develop an understanding of the QUM principles and how they particularly apply to the elderly population;
• develop an understanding of the clinical presentation, drug treatment, prevention and education of people with acute and chronic cardiovascular and renal problems, especially those living in indigenous populations and tropical areas;
• develop an understanding of transplantation physiology, therapeutic drug monitoring and treatment with respect to renal and heart/lung transplants;
• discuss the incidence and lifestyle issues causing cardiovascular and renal disease in the Australian population and the national priorities and strategies in place to address this issue;
• discuss the rational drug treatment of acute and chronic renal and cardiovascular diseases;
• outline the lifestyle issues related to the prevention of cardiovascular and renal disease in the wider community;
• outline the pathophysiology and therapeutics of cardiovascular diseases, coagulation disorders and renal disease and disorders (including nephrology and urology).

Prerequisites:	All level 2 BPharm subjects
Inadmissible Subject Combinations:	PP2231 and PP3251 and PP3252

Availabilities
Townsville, Internal, Study Period 1
Census Date 23-Mar-2017
Coordinator:	Assoc. Professor Ian Heslop
Lecturers:	Assoc. Professor Ian Heslop, Professor Beverley Glass, Mr Aaron Drovandi, Mrs Tori Llewelyn.
Contact hours:	39 hours lectures 12 hours tutorials
Assessment:	end of semester exam (60%); osce (25%); on-course assessment (15%).

Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.